Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
2.000
-0.040 (-1.96%)
Oct 6, 2025, 11:33 AM EDT - Market open
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $318.19 million as of October 6, 2025. Its market cap has decreased by -50.91% in one year.
Market Cap
318.19M
Enterprise Value
269.03M
1-Year Change
-50.91%
Ranking
Category
Stock Price
$2.00
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has increased from $124.83M to $318.19M, an increase of 154.90%. That is a compound annual growth rate of 15.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 324.56M | -40.13% |
| Dec 31, 2024 | 542.14M | 67.64% |
| Dec 29, 2023 | 323.39M | 269.38% |
| Dec 30, 2022 | 87.55M | -49.64% |
| Dec 31, 2021 | 173.85M | -28.05% |
| Dec 31, 2020 | 241.63M | 276.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |